Advocacy & Representation

Threats to Access

Compounding pharmacies play an essential role in providing life-changing and life-saving customized medications for patients. They address critical needs when FDA-approved drugs are either not appropriate or accessible. 

Patient access to compounded medications is threatened on a number of fronts, from misguided regulation to legal challenges by the pharmaceutical industry.
Along with prescribers and patients, compounding pharmacies have joined forces through APC to stand against these threats and ensure our patients maintain access to the specialized medications they rely on.

Learn MoreVisit to Learn More
Threats to Access

How We Are Helping

Determined to continue to provide the specialized medications our patients need, compounding pharmacies across the country have joined forces and are actively working with congress and other regulatory bodies to create acceptable governance, oversight and legislation for our industry.

Current Initiatives

Learn About the Threat to Compounded Hormone Therapy

Based on a flawed report that it commissioned, the FDA is signaling that it may severely restrict compounded hormones. This could be a serious health crisis for millions of people. Learn More

Drugs in Shortage

Expand access to shortage drugs via proposed legislation that would amend the way drugs are added to the FDA’s drug shortage list.

Establishing “Best Practices”

Release “best practices” documents for the membership to educate them on how to best meet patient needs with ethical compounding.

Working With Media

Help correct media misrepresentations of compounding by correcting the conflation with counterfeits and illegal online drug sales.

Recent State-Level Initiatives

In the past few months, we’ve been busy on the state regulatory front, submitting comments on bills in Illinois and Maryland and sending our new statement on peptide compounding to all state boards of pharmacy. Learn More

503B Wholesaling Guidance

We have submitted comments to several states regarding their interpretation of 503B wholesaling guidance that allows pharmacies to buy and dispense drugs made by 503B outsourcing facilities. Additionally, we have submitted comments on the California Board of Pharmacy’s proposed compounding regulations, which, if enacted as written, would further limit compounded drugs in that state.

Contact Your Representative

When your members of Congress are home in their district, it’s a perfect time for you to voice your concerns about the challenges compounders are facing. It’s as easy as calling your Congressperson’s district office and it’s the very best way to educate elected officials on compounding priorities. Learn More

Fundraising
PatientCollage1

INVEST: Compounding the Joy of Living

We are engaged in a fight to protect patient access to compounded medications. 

The threat is real and we are your advocate with FDA, in Congress, and with every state board of pharmacy.

This is the fight we have to win.

By investing in our campaign, you can help ensure we have the resources needed to educate members of Congress about this threat to millions of patients. You help raise awareness among doctors and other prescribers that they and their patients could soon lose access to vital therapy.


Whether you are a patient, a prescriber, or a pharmacist, your investment in this campaign is an investment in protecting essential compounded therapies that benefit millions of people. 

Your RECURRING gift of $100, $250, $500, or $750 a month will allow us to fund the campaign. The default investment here is $100, and you may change the dollar amount by clicking in the field and updating your desired investment amount. We hope you'll invest more.